Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias

Histopathology

Volumn 37, Issue 4, 2000, Pages 340-346

  McCluggage, W G ^a   Desai, V ^a   Manek, S ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Adenomyosis; Tamoxifen; Uterus

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; TAMOXIFEN;

ADENOMYOSIS; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; DILATATION; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIUM; FEMALE; FIBROSIS; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; METAPLASIA; MIDDLE AGED; POSTMENOPAUSE; TAMOXIFEN;

EID: 0033776927     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.01001.x     Document Type: Article

References (20)

1. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31000 recurrences and 2400 deaths among 75000 women
2. Tamoxifen for early breast cancer: An overview of the randomised trials
3. Biology of mode of action of pure antiestrogens
4. Tamoxifen and the uterus and endometrium
5. Pathology of endometrium treated with tamoxifen
6. Oestrogen-like effect of tamoxifen on vaginal epithelium
7. The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of postmenopausal women
8. Adenomyosis at hysterectomy. A study on frequency distribution and patient characteristics
9. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen
10. Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp
11. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. A new entity?
12. Tamoxifen and the endometrium: Review of 102 cases and comparison with HRT-relatedand non-HRT-related endometrial pathology
13. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1
14. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating ceils in microwave-processed formalin-fixed paraffin sections
15. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer
16. Tamoxifen-associated postmenopausal endometriosis
17. Intestinal and pelvic endometriosis presenting as a tumour and associated with tamoxifen therapy: Report of a case
18. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: A case report and review of the literature
19. Endometriosis and tamoxifen therapy
20. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature